Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Diseases ; 6(4)2018 Nov 11.
Article in English | MEDLINE | ID: mdl-30423855

ABSTRACT

Tuberculosis remains a serious health problem worldwide. Patients with tuberculosis who also require nursing care due to aging and underlying diseases are considered to have a high mortality rate; however, there are few studies describing detailed examinations of such disease conditions. OBJECTIVE: The present study was conducted to investigate differences in clinical features of elderly tuberculosis patients according to the levels of nursing and healthcare required. DESIGN: The study participants included 146 elderly (≥65 years) patients diagnosed with active tuberculosis among patients hospitalized with tuberculosis at a single center. The patients were classified into two groups: a nursing- and healthcare-associated tuberculosis group (n = 71) and a community-acquired tuberculosis group (n = 75). RESULTS: The nursing- and healthcare-associated tuberculosis patients were older and had a higher frequency of comorbidities compared with the community-acquired tuberculosis group. Patients in the nursing- and healthcare-associated tuberculosis group had markedly lower levels of serum albumin and hemoglobin, and higher levels of C-reactive protein. The rate of in-hospital death was significantly higher in the nursing- and healthcare-associated tuberculosis group. This was attributed to malnutrition and comorbid conditions rather than the severity of tuberculosis. CONCLUSION: The prognosis was poor in elderly tuberculosis patients receiving nursing and healthcare.

2.
Stem Cells Transl Med ; 6(3): 720-730, 2017 03.
Article in English | MEDLINE | ID: mdl-28297575

ABSTRACT

Donor-independent platelet concentrates for transfusion can be produced in vitro from induced pluripotent stem cells (iPSCs). However, culture at 37°C induces ectodomain shedding on platelets of glycoprotein Ibα (GPIbα), the von Willebrand factor receptor critical for adhesive function and platelet lifetime in vivo, through temperature-dependent activation of a disintegrin and metalloproteinase 17 (ADAM17). The shedding can be suppressed by using inhibitors of panmetalloproteinases and possibly of the upstream regulator p38 mitogen-activated protein kinase (p38 MAPK), but residues of these inhibitors in the final platelet products may be accompanied by harmful risks that prevent clinical application. Here, we optimized the culture conditions for generating human iPSC-derived GPIbα+ platelets, focusing on culture temperature and additives, by comparing a new and safe selective ADAM17 inhibitor, KP-457, with previous inhibitors. Because cultivation at 24°C (at which conventional platelet concentrates are stored) markedly diminished the yield of platelets with high expression of platelet receptors, 37°C was requisite for normal platelet production from iPSCs. KP-457 blocked GPIbα shedding from iPSC platelets at a lower half-maximal inhibitory concentration than panmetalloproteinase inhibitor GM-6001, whereas p38 MAPK inhibitors did not. iPSC platelets generated in the presence of KP-457 exhibited improved GPIbα-dependent aggregation not inferior to human fresh platelets. A thrombus formation model using immunodeficient mice after platelet transfusion revealed that iPSC platelets generated with KP-457 exerted better hemostatic function in vivo. Our findings suggest that KP-457, unlike GM-6001 or p38 MAPK inhibitors, effectively enhances the production of functional human iPSC-derived platelets at 37°C, which is an important step toward their clinical application. Stem Cells Translational Medicine 2017;6:720-730.


Subject(s)
ADAM17 Protein/antagonists & inhibitors , Blood Platelets/metabolism , Induced Pluripotent Stem Cells/cytology , Platelet Glycoprotein GPIb-IX Complex/metabolism , ADAM17 Protein/metabolism , Aging/metabolism , Blood Platelets/drug effects , Blood Platelets/ultrastructure , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Cells, Cultured , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Hemostasis/drug effects , Humans , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/ultrastructure , Megakaryocytes/drug effects , Megakaryocytes/metabolism , Temperature , Thrombopoiesis/drug effects
3.
Surg Case Rep ; 2(1): 93, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27612868

ABSTRACT

Congenital esophagobronchial fistula (EBF) is rarely seen in adults. We report a case of EBF detected in adulthood with a destroyed lung. A 67-year-old man experienced repeated pneumonia during his childhood. Since the age of 38, he had often suffered from bloody phlegm and always had a cough and sputum during oral intake. Before cardiac surgery for atrial fibrillation and valvular disease, computed tomography (CT) detected bronchiectasis, which could cause pulmonary bleeding during heart surgery, and the patient was introduced to our hospital for lung resection. A fistula between the esophagus and the right lower lung lobe was found using CT, esophagoscopy, and esophagography. Contrast CT and angiography revealed an abnormal artery branching from the inferior phrenic artery into the lobe. As indicated by intraoperative findings, the middle and lower lobes had strongly adhered to chest wall and diaphragm, but we located the fistula easily without adhesion to the surroundings, severed it using an automatic stapler, and resected the middle and lower lobes. The symptoms disappeared immediately, and the patient was uneventfully discharged.The diagnosis of congenital EBF was established with intraoperative findings and pathological exam. The existence of pulmonary sequestration was suggested because of the long-term absence of any symptoms during his adulthood, the tract of the EBF running into the lung, not directly into the bronchus, and a septum pathologically detected in the right lower lobe. A congenital EBF should be considered for differential diagnosis in cases of limited bronchiectasis in elderly people.

4.
J Clin Invest ; 123(9): 3802-14, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23908116

ABSTRACT

Congenital amegakaryocytic thrombocytopenia (CAMT) is caused by the loss of thrombopoietin receptor-mediated (MPL-mediated) signaling, which causes severe pancytopenia leading to bone marrow failure with onset of thrombocytopenia and anemia prior to leukopenia. Because Mpl(-/-) mice do not exhibit the human disease phenotype, we used an in vitro disease tracing system with induced pluripotent stem cells (iPSCs) derived from a CAMT patient (CAMT iPSCs) and normal iPSCs to investigate the role of MPL signaling in hematopoiesis. We found that MPL signaling is essential for maintenance of the CD34+ multipotent hematopoietic progenitor (MPP) population and development of the CD41+GPA+ megakaryocyte-erythrocyte progenitor (MEP) population, and its role in the fate decision leading differentiation toward megakaryopoiesis or erythropoiesis differs considerably between normal and CAMT cells. Surprisingly, complimentary transduction of MPL into normal or CAMT iPSCs using a retroviral vector showed that MPL overexpression promoted erythropoiesis in normal CD34+ hematopoietic progenitor cells (HPCs), but impaired erythropoiesis and increased aberrant megakaryocyte production in CAMT iPSC-derived CD34+ HPCs, reflecting a difference in the expression of the transcription factor FLI1. These results demonstrate that impaired transcriptional regulation of the MPL signaling that normally governs megakaryopoiesis and erythropoiesis underlies CAMT.


Subject(s)
Induced Pluripotent Stem Cells/metabolism , Receptors, Thrombopoietin/metabolism , Thrombocytopenia/metabolism , Blood Platelets/metabolism , Cell Differentiation , Cells, Cultured , Congenital Bone Marrow Failure Syndromes , Erythrocytes/physiology , Gene Expression Regulation , Hematopoiesis , Humans , Megakaryocytes/physiology , Mutation, Missense , Phenotype , Platelet Glycoprotein GPIb-IX Complex/metabolism , Proto-Oncogene Protein c-fli-1/physiology , Receptors, Thrombopoietin/genetics , Signal Transduction , Thrombocytopenia/genetics , Thrombocytopenia/pathology , Transcription, Genetic
5.
J Exp Med ; 207(13): 2817-30, 2010 Dec 20.
Article in English | MEDLINE | ID: mdl-21098095

ABSTRACT

Human (h) induced pluripotent stem cells (iPSCs) are a potentially abundant source of blood cells, but how best to select iPSC clones suitable for this purpose from among the many clones that can be simultaneously established from an identical source is not clear. Using an in vitro culture system yielding a hematopoietic niche that concentrates hematopoietic progenitors, we show that the pattern of c-MYC reactivation after reprogramming influences platelet generation from hiPSCs. During differentiation, reduction of c-MYC expression after initial reactivation of c-MYC expression in selected hiPSC clones was associated with more efficient in vitro generation of CD41a(+)CD42b(+) platelets. This effect was recapitulated in virus integration-free hiPSCs using a doxycycline-controlled c-MYC expression vector. In vivo imaging revealed that these CD42b(+) platelets were present in thrombi after laser-induced vessel wall injury. In contrast, sustained and excessive c-MYC expression in megakaryocytes was accompanied by increased p14 (ARF) and p16 (INK4A) expression, decreased GATA1 expression, and impaired production of functional platelets. These findings suggest that the pattern of c-MYC expression, particularly its later decline, is key to producing functional platelets from selected iPSC clones.


Subject(s)
Blood Platelets/cytology , Gene Expression Regulation , Induced Pluripotent Stem Cells/cytology , Proto-Oncogene Proteins c-myc/genetics , Animals , Blood Platelets/metabolism , Blood Platelets/ultrastructure , Cell Culture Techniques , Cell Differentiation , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Flow Cytometry , Humans , Induced Pluripotent Stem Cells/metabolism , Male , Megakaryocytes/cytology , Megakaryocytes/metabolism , Mice , Mice, Inbred NOD , Mice, SCID , Microscopy, Electron, Transmission , Octamer Transcription Factor-3/genetics , Octamer Transcription Factor-3/metabolism , Platelet Glycoprotein GPIb-IX Complex/metabolism , Platelet Membrane Glycoprotein IIb/metabolism , Platelet Transfusion , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Thrombocytopenia/therapy , Tumor Suppressor Protein p14ARF/genetics , Tumor Suppressor Protein p14ARF/metabolism
6.
Food Chem Toxicol ; 48(1): 429-35, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19883715

ABSTRACT

Polyphenols present in foods and supplements may contribute to human health by preventing cardiovascular diseases and cancer. Drug-food or drug-herb interactions have recently come into focus but, except for some phytochemicals, few components of food or herbs participate in such interactions. In this study, we systematically evaluated the inhibitory effects of 60 polyphenols and related compounds on human cytochrome P450 (CYP) 3A4 and CYP2C9 activity by in vitro assay to investigate whether some polyphenols induce drug interactions. In addition, the kinetics of potent CYP inhibitors was investigated by Lineweaver-Burk plot analysis. Three coumarins and 12 flavonoids significantly suppressed CYP3A4 or CYP2C9 activities. Lineweaver-Burk plot analysis indicated that apigenin and its dimer amentoflavone and imperatorin displayed a mixed type of inhibition on CYP3A4 or CYP2C9. Among the inhibitors, amentoflavone was the most potent inhibitor of CYP3A4 and CYP2C9 activities with IC(50) values of 0.07 and 0.03 microM, respectively. The K(i) value of amentoflavone was significantly lower than that of the CYP2C9 inhibition positive control sulfaphenazole. These findings suggest that some dietary polyphenols may have the potential to inhibit the metabolism of clinical drugs.


Subject(s)
Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors , Cytochrome P-450 CYP3A Inhibitors , Enzyme Inhibitors , Flavonoids/pharmacology , Phenols/pharmacology , Biflavonoids/chemistry , Biflavonoids/pharmacology , Chromatography, High Pressure Liquid , Cytochrome P-450 CYP2C9 , Cytochrome P-450 CYP3A , Humans , Kinetics , Magnetic Resonance Spectroscopy , Pharmaceutical Preparations/metabolism , Polyphenols , Spectrometry, Mass, Electrospray Ionization
7.
Nihon Kokyuki Gakkai Zasshi ; 47(11): 985-90, 2009 Nov.
Article in Japanese | MEDLINE | ID: mdl-19994592

ABSTRACT

We evaluated both the short-and long-term efficacy of micafungin in patients with chronic pulmonary aspergillosis (CPA). We treated 26 patients with CPA, 19 with chronic necrotizing pulmonary aspergillosis (CNPA) and 7 with aspergilloma, with micafungin between February 2003 and September 2005. On completion of treatment (short-term efficacy evaluation), the efficacy rates of micafungin for CNPA and aspergilloma were 52.6% (10/19) and 71.4% (5/7), respectively, and the overall efficacy rate was 57.7% (15/26). Long-term efficacy was evaluable in 25 of 26 patients, and 15 patients, who responded favorably to micafungin, received maintenance therapy with itraconazole (200mg). In long-term efficacy evaluation, 10 patients were unchanged, but in 5 patients symptoms were exacerbated after 1.8 months (median time). This result suggests that establishing effective maintenance therapy, as well as acute-phase therapy, is important in the treatment of patients with CPA.


Subject(s)
Antifungal Agents/therapeutic use , Echinocandins/therapeutic use , Itraconazole/administration & dosage , Lipopeptides/therapeutic use , Pulmonary Aspergillosis/drug therapy , Adult , Aged , Aged, 80 and over , Chronic Disease , Female , Humans , Male , Micafungin , Middle Aged
8.
Biosci Biotechnol Biochem ; 70(10): 2560-3, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17031047

ABSTRACT

Chlorogenic acid possessed a weak caffeine-like psychostimulant property when assessed for its effect on spontaneous locomotor activity in mice. In the evaluation of the effects for the major metabolites of chlorogenic acid which were detected upon incubation with rat feces and/or excreted in urine after oral administration to rats, caffeic and m-coumaric acids were found to be the principal active metabolites, while the others contributed little to this caffeine-like psychostimulant activity.


Subject(s)
Chlorogenic Acid/metabolism , Chlorogenic Acid/pharmacology , Motor Activity/drug effects , Animals , Caffeic Acids/analysis , Caffeic Acids/pharmacology , Central Nervous System Stimulants/metabolism , Central Nervous System Stimulants/pharmacology , Chlorogenic Acid/urine , Chromatography, High Pressure Liquid , Coumaric Acids/analysis , Coumaric Acids/pharmacology , Feces , Flavonoids , Male , Mice , Mice, Inbred Strains , Phenols , Polyphenols , Rats
9.
Biosci Biotechnol Biochem ; 70(7): 1681-7, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16861803

ABSTRACT

Cranberry, which is rich in polyphenols, including anthocyanins and proanthocyanidins, has been found to have various effects beneficial to human health, including prevention of urinary tract infections. These effects have been associated with polyphenols in the fruit. We investigated the excretion of anthocyanins in human urine after ingestion of cranberry juice. Eleven healthy volunteers consumed 200 ml of cranberry juice containing 650.8 microg total anthocyanins. Urine samples were collected within 24 h before and after consumption. Six of 12 anthocyanins identified in cranberry were quantified in human urine by HPLC coupled with electrospray ionization and tandem mass spectrometry (HPLC-ESI-MS-MS). Among these, peonidin 3-O-galactoside, the second most plentiful anthocyanin in the juice, was found most abundantly in urine within 24 h, corresponding to 41.5 nmol (56.1% of total anthocyanins). The urinary levels of anthocyanins reached a maximum between 3 and 6 h after ingestion, and the recovery of total anthocyanins in the urine over 24 h was estimated to be 5.0% of the amount consumed. This study found high absorption and excretion of cranberry anthocyanins in human urine.


Subject(s)
Anthocyanins/urine , Beverages , Vaccinium macrocarpon/chemistry , Adult , Chromatography, High Pressure Liquid , Female , Humans , Male , Spectrometry, Mass, Electrospray Ionization
10.
J Cell Sci ; 118(Pt 24): 5885-98, 2005 Dec 15.
Article in English | MEDLINE | ID: mdl-16339970

ABSTRACT

Alpha-satellite (alphoid) DNA is necessary for de novo formation of human artificial chromosomes (HACs) in human cultured cells. To investigate the relationship among centromeric, transcriptionally permissive and non-permissive chromatin assemblies on de novo HAC formation, we constructed bacterial artificial chromosome (BAC)-based linear HAC vectors whose left vector arms are occupied by beta geo coding genes with or without a functional promoter in addition to a common marker gene on the right arm. Although HACs were successfully generated from the vectors with promoter-less constructs on the left arm in HT1080 cells, we failed to generate a stable HAC from the vectors with a functional promoter on the left arm. Despite this failure in HAC formation, centromere components (CENP-A, CENP-B and CENP-C) assembled at the integration sites correlating with a transcriptionally active state of both marker genes on the vector arms. However, on the stable HAC, chromatin immunoprecipitation analysis showed that HP1alpha and trimethyl histone H3-K9 were enriched at the non-transcribing left vector arm. A transcriptionally active state on both vector arms is not compatible with heterochromatin formation on the introduced BAC DNA, suggesting that epigenetic assembly of heterochromatin is distinct from centromere chromatin assembly and is required for the establishment of a stable artificial chromosome.


Subject(s)
Chromatin Assembly and Disassembly/physiology , Chromosomes, Artificial, Human/metabolism , DNA, Satellite/metabolism , Epigenesis, Genetic , Heterochromatin/metabolism , Kinetochores/metabolism , Cell Line, Tumor , Chromobox Protein Homolog 5 , Chromosomes, Artificial, Human/genetics , Histones/metabolism , Humans , Transcription, Genetic/physiology
11.
Eur J Pharmacol ; 504(3): 185-9, 2004 Nov 19.
Article in English | MEDLINE | ID: mdl-15541420

ABSTRACT

The effect of chlorogenic acid on the sleep-wakefulness cycle in rats was investigated in comparison with those of caffeic acid (the metabolite of chlorogenic acid) and dihydrocaffeic acid (the metabolite of caffeic acid). A significant prolongation of sleep latency was observed with chlorogenic acid and caffeic acid at a dose of 500 and 200 mg/kg, respectively. On the other hand, no remarkable effects were observed with dihydrocaffeic acid even at a dose of 500 mg/kg. Caffeine caused a significant increase in sleep latency and waking time and decrease in non-rapid eye movement sleep time at a dose of 10 mg/kg. In contrast, chlorogenic acid and its metabolites had no significant effects on each sleep state. From these results, it may be concluded that chrologenic acid caused a mild arousal effect compared with that of caffeine, and the effect of chlorogenic acid may have occurred through its metabolite caffeic acid.


Subject(s)
Chlorogenic Acid/pharmacology , Sleep/drug effects , Wakefulness/drug effects , Animals , Antioxidants/pharmacology , Caffeic Acids/pharmacology , Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Dose-Response Relationship, Drug , Electroencephalography/drug effects , Electromyography/drug effects , Male , Rats , Rats, Wistar , Sleep, REM/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...